BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19747339)

  • 1. Consensus statement on the management of chronic hand eczema.
    English J; Aldridge R; Gawkrodger DJ; Kownacki S; Statham B; White JM; Williams J
    Clin Exp Dermatol; 2009 Oct; 34(7):761-9. PubMed ID: 19747339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Chronic Hand Eczema.
    de León FJ; Berbegal L; Silvestre JF
    Actas Dermosifiliogr; 2015 Sep; 106(7):533-44. PubMed ID: 26005193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alitretinoin for the treatment of severe chronic hand eczema.
    Paulden M; Rodgers M; Griffin S; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
    Health Technol Assess; 2010 May; 14 Suppl 1():39-46. PubMed ID: 20507802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hand eczema].
    Berthold E; Weisshaar E
    Hautarzt; 2019 Oct; 70(10):790-796. PubMed ID: 31515578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: seven case studies.
    English J; Graham-Brown R; de Sica Chapman A; Alexandroff AB
    Clin Exp Dermatol; 2011 Mar; 36 Suppl():1-2. PubMed ID: 21309810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of chronic hand eczema].
    Lahfa M
    Ann Dermatol Venereol; 2014 Jun; 141 Suppl 1():S143-50. PubMed ID: 24953623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alitretinoin on quality of life of patients having chronic hand eczema: an observational study.
    Gola M; D'Erme AM; Milanesi N; Marmugi L
    Dermatitis; 2013; 24(4):166-9. PubMed ID: 23857016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment for chronic hand eczema].
    Molin S; Ruzicka T
    MMW Fortschr Med; 2009 May; 151(19):35-7. PubMed ID: 19827442
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alitretinoin: a new treatment option for chronic refractory hand eczema].
    Molin S; Ruzicka T
    Hautarzt; 2008 Sep; 59(9):703-4, 706-9. PubMed ID: 18704345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
    Fowler JF; Graff O; Hamedani AG
    J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation and assessment of the therapeutic efficacy of alitretinoin in a group of patients with chronic hand eczema refractory to topical steroid therapy.
    Gola M; Milanesi N; D'Erme AM
    G Ital Dermatol Venereol; 2014 Aug; 149(4):435-9. PubMed ID: 25068232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of chronic hand eczema.
    Diepgen TL; Agner T; Aberer W; Berth-Jones J; Cambazard F; Elsner P; McFadden J; Coenraads PJ
    Contact Dermatitis; 2007 Oct; 57(4):203-10. PubMed ID: 17868211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of alitretinoin depending on the concomitant use of topical corticosteroids in chronic hand eczema patients.
    Cheon DU; Kim JE; Ko JY; Ro YS
    J Dermatol; 2019 Nov; 46(11):998-1005. PubMed ID: 31535403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
    Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
    Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
    Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
    Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study.
    Politiek K; Christoffers WA; Coenraads PJ; Schuttelaar MA
    Dermatol Ther; 2016 Sep; 29(5):364-371. PubMed ID: 27146260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
    Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
    Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of two topical corticosteroids in the management of chronic hand eczema.
    Gola M; D'Erme AM; Milanesi N
    G Ital Dermatol Venereol; 2015 Jun; 150(3):293-6. PubMed ID: 25946672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and provision of care in patients with chronic hand eczema: updated data from the CARPE registry.
    Apfelbacher C; Molin S; Weisshaar E; Bauer A; Elsner P; Mahler V; Weiss M; Ruzicka T; Diepgen TL
    Acta Derm Venereol; 2014 Mar; 94(2):163-7. PubMed ID: 23995048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Atopic Hand Dermatitis.
    Halling-Overgaard AS; Zachariae C; Thyssen JP
    Dermatol Clin; 2017 Jul; 35(3):365-372. PubMed ID: 28577805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.